Calendar BerGenBio ASA

Equities

BGBIO

NO0010650013

Market Closed - Oslo Bors 10:45:00 2024-04-23 am EDT 5-day change 1st Jan Change
0.157 NOK -0.25% Intraday chart for BerGenBio ASA -4.27% -43.53%

Chart calendar BerGenBio ASA

48e1c2da1e69cb2b9f4d13ba130502e.XknYDxZGets6dzR9UkCeJT3IMAbhhx3ncHnxqOhR4yA.GDnuRFd1Q5QOWl0uIgrzTXOkY0OO407WIjKBydkoqngmGoBMIHAVnG4wWw~5ad85259150bb4383f94226f64a9578b

Upcoming events on BerGenBio ASA

2024-05-22 Annual General Meeting
2024-05-29 01:00 am Q1 2024 Earnings Release
2024-08-21 01:00 am Q2 2024 Earnings Release
2024-11-13 01:00 am Q3 2024 Earnings Release
2025-02-19 01:00 am Q4 2024 Earnings Release
2025-05-13 Q1 2025 Earnings Release (Projected)
2025-08-25 Q2 2025 Earnings Release (Projected)
2025-11-17 Q3 2025 Earnings Release (Projected)
2026-02-16 Q4 2025 Earnings Release (Projected)

Past events on BerGenBio ASA

2024-02-14 04:00 am Q4 2023 Earnings Call
2024-02-14 01:00 am Q4 2023 Earnings Release
2023-11-14 04:00 am Q3 2023 Earnings Call
2023-11-14 01:20 am Q3 2023 Earnings Release
2023-11-04 12:00 pm Society for Immunotherapy of Cancer Meeting - Poster Board Number: 598
2023-10-22 European Society for Medical Oncology Congress - Poster Number: 1440P
2023-10-21 09:50 am European Society for Medical Oncology Congress
2023-08-23 04:45 am Q2 2023 Earnings Call
2023-08-23 01:00 am Q2 2023 Earnings Release
2023-06-22 01:00 am Q1 2023 Earnings Release
2023-06-04 American Society of Clinical Oncology Meeting
2023-06-02 05:00 am Arctic Securities and Carnegie Conference
2023-05-22 04:00 pm Annual General Meeting
2023-05-15 04:00 am Business Update Call
2023-02-16 04:00 am FY 2022 Earnings Call
2023-02-16 01:00 am FY 2022 Earnings Release
2022-11-15 04:00 am Q3 2022 Earnings Call
2022-11-15 01:07 am Q3 2022 Earnings Release
2022-08-23 04:00 am Interim 2022 Earnings Call
2022-08-23 01:36 am Interim 2022 Earnings Release

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022 2023
Net sales
Million NOK
Released
Forecast
Spread
2,34
0,00
-
8,90
8,70
2.3%
0,60
0,00
-
0,80
0,00
-
0,39
0,00
-
0,35
0,00
-
EBITDA
Million NOK
Released
Forecast
Spread
-194
-200
2.83%
-204
-201
-1.49%
-260
-258
-0.97%
-313
-320
2.06%
-305
-317
3.86%
-192
-221
13.41%
EBIT
Million NOK
Released
Forecast
Spread
-195
-190
-2.25%
-204
-200
-2.2%
-261
-259
-0.96%
-315
-321
2.15%
-306
-314
2.56%
-192
-222
13.51%
Earnings before Tax (EBT)
Million NOK
Released
Forecast
Spread
-192
-198
2.91%
-199
-196
-1.8%
-257
-250
-2.78%
-309
-314
1.35%
-302
-309
2.35%
-190
-221
13.71%
Net income
Million NOK
Released
Forecast
Spread
-192
-198
2.94%
-199
-196
-1.8%
-257
-250
-2.78%
-309
-314
1.35%
-302
-309
2.35%
-190
-221
13.71%
EPS
NOK
Released
Forecast
Spread
-3,60
-3,80
5.26%
-3,43
-3,37
-1.78%
-3,43
-3,42
-0.41%
-3,52
-3,57
1.32%
-3,41
-3,49
2.38%
-0,13
-0,13
2.82%
Announcement Date12/02/1911/02/2010/02/2116/02/2216/02/2314/02/24

Quarterly results

Fiscal PeriodDecember 2019 S1 2020 S1 2021 S1 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4
Net sales
Million NOK
Released
Forecast
Spread
8,68
8,68
0.02%
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,80
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,39
0,00
-






0,00
0,00
-
0,35
0,00
-

0,00


0,00


0,00


0,00


0,00

EBITDA
Million NOK
Released
Forecast
Spread









-71,1
-93,0
23.57%
-67,0
-65,0
-3.1%
-78,2
-68,8
-13.82%
-87,9
-73,8
-19.22%



-62,3
-83,8
25.63%
-76,3
-82,0
6.93%
-72,4
-100
27.58%



-28,0
-57,6
51.42%
-43,4
-33,4
-30.07%

-46,2


-48,3


-94,5


-51,9


-56,5

EBIT
Million NOK
Released
Forecast
Spread






-176
-168
-4.85%
-71,4
-94,0
24.02%
-67,3
-70,7
4.81%
-78,6
-70,0
-12.18%
-88,2
-75,0
-17.53%
-167
-155
-7.89%
-62,4
-84,1
25.75%
-76,4
-89,1
14.23%
-72,4
-100
27.81%






-43,5
-33,4
-30.37%















Earnings before Tax (EBT)
Million NOK
Released
Forecast
Spread
-97,1
-97,7
0.62%
-116
-102
-13.23%
-170
-164
-3.78%
-70,5
-92,3
23.58%
-68,8
-69,2
0.56%
-81,1
-68,9
-17.64%
-84,1
-73,9
-13.73%
-165
-156
-5.79%
-59,8
-82,8
27.8%
-77,2
-81,7
5.48%
-72,0
-99,8
27.88%



-27,9
-58,3
52.09%
-41,6
-33,5
-24.28%

-45,1


-47,3


-92,3


-51,6


-57,6

Net income
Million NOK
Released
Forecast
Spread
-97,1
-97,7
0.62%
-116
-102
-13.23%
-170
-164
-3.78%
-70,5
-92,3
23.58%
-68,8
-69,2
0.56%
-81,1
-68,9
-17.64%
-84,1
-73,9
-13.74%
-165
-156
-5.79%
-59,8
-82,8
27.8%
-77,2
-81,7
5.48%
-72,0
-99,8
27.88%
-48,8


-27,9
-58,3
52.09%
-41,6
-33,5
-24.28%

-45,1


-47,3


-92,3


-51,6


-57,6

EPS
NOK
Released
Forecast
Spread
-1,76
-1,70
-3.53%
-1,59
-1,33
-19.55%
-1,94
-1,86
-4.3%
-0,80
-1,03
22.33%
-0,78
-0,81
3.7%
-0,92
-0,78
-17.95%
-0,95
-0,83
-14.46%
-1,86
-1,75
-6.29%



-0,87
-0,85
-2.35%



-0,15


-0,01
-0,02
50%
-0,02
-0,01
-100%

-0,02


-0,02


-0,03


-0,02


-0,02

Announcement Date19/08/1917/08/2017/08/2116/11/2116/02/2224/05/2223/08/2223/08/2215/11/2216/02/2322/06/2323/08/2314/11/2314/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BGBIO Stock
  4. Calendar BerGenBio ASA